“…We tested if transient PLX5622 exposure moderates the behavioral, biochemical, and histological consequences of α-synucleinopathy in our model of limbic Lewy body disease ( Bhatia et al, 2021 ; Mason et al, 2016 ; Mason et al, 2019 ; Miner et al, 2022 ). In the PFF model, the density of Lewy-like pathology typically peaks ~8 weeks later in first-order afferents ( Duffy et al, 2018b ; Patterson et al, 2019 ; Paumier et al, 2015 ; Stoll and Sortwell, 2022 ).…”